EMEA (Europe, Middle East and Africa) Devices for Inhaled Medications Market Report 2017

October 2017 | 122 pages | ID: E19809804E2PEN
QYResearch

Abstracts

In this report, the EMEA Devices for Inhaled Medications market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Devices for Inhaled Medications for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Devices for Inhaled Medications market competition by top manufacturers/players, with Devices for Inhaled Medications sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Consort Medical
• Inhalexper
• Cambridge Consultants
• Hovione
• Catalent, Inc
• VertMarkets, Inc
• Qualicaps
• 3M
• Aerovance
• AstraZeneca
• Boehringer Ingelheim
• Chiesi
• Cipla
• Civitas/Alkermes
• GlaxoSmithKline
• Hovione
• Mannkind
• Mantecorp
• Meda
• MicroDose Therapeutx
• Novartis

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Dry Powder Inhalers
• Metered-Dose Inhalers
• Nebulizers
• Soft Mist Inhaler

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Devices for Inhaled Medications for each application, including

• Clinic
• Hospital
• Home

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Devices for Inhaled Medications Market Report 2017

1 DEVICES FOR INHALED MEDICATIONS OVERVIEW

1.1 Product Overview and Scope of Devices for Inhaled Medications
1.2 Classification of Devices for Inhaled Medications
  1.2.1 EMEA Devices for Inhaled Medications Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Devices for Inhaled Medications Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Dry Powder Inhalers
  1.2.4 Metered-Dose Inhalers
  1.2.5 Nebulizers
  1.2.6 Soft Mist Inhaler
1.3 EMEA Devices for Inhaled Medications Market by Application/End Users
  1.3.1 EMEA Devices for Inhaled Medications Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Home
1.4 EMEA Devices for Inhaled Medications Market by Region
  1.4.1 EMEA Devices for Inhaled Medications Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Devices for Inhaled Medications (2012-2022)
  1.5.1 EMEA Devices for Inhaled Medications Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Devices for Inhaled Medications Revenue and Growth Rate (2012-2022)

2 EMEA DEVICES FOR INHALED MEDICATIONS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Devices for Inhaled Medications Market Competition by Players/Manufacturers
  2.1.1 EMEA Devices for Inhaled Medications Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Devices for Inhaled Medications Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Devices for Inhaled Medications Sale Price by Players (2012-2017)
2.2 EMEA Devices for Inhaled Medications (Volume and Value) by Type/Product Category
  2.2.1 EMEA Devices for Inhaled Medications Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Devices for Inhaled Medications Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Devices for Inhaled Medications Sale Price by Type (2012-2017)
2.3 EMEA Devices for Inhaled Medications (Volume) by Application
2.4 EMEA Devices for Inhaled Medications (Volume and Value) by Region
  2.4.1 EMEA Devices for Inhaled Medications Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Devices for Inhaled Medications Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Devices for Inhaled Medications Sales Price by Region (2012-2017)

3 EUROPE DEVICES FOR INHALED MEDICATIONS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Devices for Inhaled Medications Sales and Value (2012-2017)
  3.1.1 Europe Devices for Inhaled Medications Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Devices for Inhaled Medications Revenue and Growth Rate (2012-2017)
3.2 Europe Devices for Inhaled Medications Sales and Market Share by Type
3.3 Europe Devices for Inhaled Medications Sales and Market Share by Application
3.4 Europe Devices for Inhaled Medications Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Devices for Inhaled Medications Sales Volume by Countries (2012-2017)
  3.4.2 Europe Devices for Inhaled Medications Revenue by Countries (2012-2017)
  3.4.3 Germany Devices for Inhaled Medications Sales and Growth Rate (2012-2017)
  3.4.4 France Devices for Inhaled Medications Sales and Growth Rate (2012-2017)
  3.4.5 UK Devices for Inhaled Medications Sales and Growth Rate (2012-2017)
  3.4.6 Russia Devices for Inhaled Medications Sales and Growth Rate (2012-2017)
  3.4.7 Italy Devices for Inhaled Medications Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Devices for Inhaled Medications Sales and Growth Rate (2012-2017)

4 MIDDLE EAST DEVICES FOR INHALED MEDICATIONS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Devices for Inhaled Medications Sales and Value (2012-2017)
  4.1.1 Middle East Devices for Inhaled Medications Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Devices for Inhaled Medications Revenue and Growth Rate (2012-2017)
4.2 Middle East Devices for Inhaled Medications Sales and Market Share by Type
4.3 Middle East Devices for Inhaled Medications Sales and Market Share by Application
4.4 Middle East Devices for Inhaled Medications Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Devices for Inhaled Medications Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Devices for Inhaled Medications Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Devices for Inhaled Medications Sales and Growth Rate (2012-2017)
  4.4.4 Israel Devices for Inhaled Medications Sales and Growth Rate (2012-2017)
  4.4.5 UAE Devices for Inhaled Medications Sales and Growth Rate (2012-2017)
  4.4.6 Iran Devices for Inhaled Medications Sales and Growth Rate (2012-2017)

5 AFRICA DEVICES FOR INHALED MEDICATIONS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Devices for Inhaled Medications Sales and Value (2012-2017)
  5.1.1 Africa Devices for Inhaled Medications Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Devices for Inhaled Medications Revenue and Growth Rate (2012-2017)
5.2 Africa Devices for Inhaled Medications Sales and Market Share by Type
5.3 Africa Devices for Inhaled Medications Sales and Market Share by Application
5.4 Africa Devices for Inhaled Medications Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Devices for Inhaled Medications Sales Volume by Countries (2012-2017)
  5.4.2 Africa Devices for Inhaled Medications Revenue by Countries (2012-2017)
  5.4.3 South Africa Devices for Inhaled Medications Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Devices for Inhaled Medications Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Devices for Inhaled Medications Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Devices for Inhaled Medications Sales and Growth Rate (2012-2017)

6 EMEA DEVICES FOR INHALED MEDICATIONS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Consort Medical
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Devices for Inhaled Medications Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Consort Medical Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Inhalexper
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Devices for Inhaled Medications Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Inhalexper Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Cambridge Consultants
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Devices for Inhaled Medications Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Cambridge Consultants Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Hovione
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Devices for Inhaled Medications Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hovione Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Catalent, Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Devices for Inhaled Medications Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Catalent, Inc Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 VertMarkets, Inc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Devices for Inhaled Medications Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 VertMarkets, Inc Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Qualicaps
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Devices for Inhaled Medications Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Qualicaps Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 3M
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Devices for Inhaled Medications Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 3M Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Aerovance
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Devices for Inhaled Medications Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Aerovance Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 AstraZeneca
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Devices for Inhaled Medications Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AstraZeneca Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Boehringer Ingelheim
6.12 Chiesi
6.13 Cipla
6.14 Civitas/Alkermes
6.15 GlaxoSmithKline
6.16 Hovione
6.17 Mannkind
6.18 Mantecorp
6.19 Meda
6.20 MicroDose Therapeutx
6.21 Novartis

7 DEVICES FOR INHALED MEDICATIONS MANUFACTURING COST ANALYSIS

7.1 Devices for Inhaled Medications Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Devices for Inhaled Medications

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Devices for Inhaled Medications Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Devices for Inhaled Medications Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA DEVICES FOR INHALED MEDICATIONS MARKET FORECAST (2017-2022)

11.1 EMEA Devices for Inhaled Medications Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Devices for Inhaled Medications Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Devices for Inhaled Medications Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Devices for Inhaled Medications Price and Trend Forecast (2017-2022)
11.2 EMEA Devices for Inhaled Medications Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Devices for Inhaled Medications Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Devices for Inhaled Medications Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Devices for Inhaled Medications Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Devices for Inhaled Medications Sales Forecast by Type (2017-2022)
11.7 EMEA Devices for Inhaled Medications Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Devices for Inhaled Medications
Figure EMEA Devices for Inhaled Medications Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Devices for Inhaled Medications Sales Volume Market Share by Type (Product Category) in 2016
Figure Dry Powder Inhalers Product Picture
Figure Metered-Dose Inhalers Product Picture
Figure Nebulizers Product Picture
Figure Soft Mist Inhaler Product Picture
Figure EMEA Devices for Inhaled Medications Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Devices for Inhaled Medications by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Home Examples
Table Key Downstream Customer in Home
Figure EMEA Devices for Inhaled Medications Market Size (Million USD) by Region (2012-2022)
Figure Europe Devices for Inhaled Medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Devices for Inhaled Medications Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Devices for Inhaled Medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Devices for Inhaled Medications Revenue (Million USD) Status and Forecast by Countries
Figure Africa Devices for Inhaled Medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Devices for Inhaled Medications Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Devices for Inhaled Medications Sales Volume and Growth Rate (2012-2022)
Figure EMEA Devices for Inhaled Medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Devices for Inhaled Medications Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Devices for Inhaled Medications Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Devices for Inhaled Medications Sales Share by Players (2012-2017)
Figure 2016 Devices for Inhaled Medications Sales Share by Players
Figure 2017 Devices for Inhaled Medications Sales Share by Players
Figure EMEA Devices for Inhaled Medications Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Devices for Inhaled Medications Revenue (Million USD) by Players (2012-2017)
Table EMEA Devices for Inhaled Medications Revenue Share by Players (2012-2017)
Table 2016 EMEA Devices for Inhaled Medications Revenue Share by Players
Table 2017 EMEA Devices for Inhaled Medications Revenue Share by Players
Table EMEA Devices for Inhaled Medications Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Devices for Inhaled Medications Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Devices for Inhaled Medications Sales Share by Type (2012-2017)
Figure Sales Market Share of Devices for Inhaled Medications by Type (2012-2017)
Figure EMEA Devices for Inhaled Medications Sales Market Share by Type (2012-2017)
Table EMEA Devices for Inhaled Medications Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Devices for Inhaled Medications Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Devices for Inhaled Medications by Type in 2016
Table EMEA Devices for Inhaled Medications Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Devices for Inhaled Medications Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Devices for Inhaled Medications Sales Share by Application (2012-2017)
Figure Sales Market Share of Devices for Inhaled Medications by Application (2012-2017)
Figure EMEA Devices for Inhaled Medications Sales Market Share by Application in 2016
Table EMEA Devices for Inhaled Medications Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Devices for Inhaled Medications Sales Share by Region (2012-2017)
Figure Sales Market Share of Devices for Inhaled Medications by Region (2012-2017)
Figure EMEA Devices for Inhaled Medications Sales Market Share in 2016
Table EMEA Devices for Inhaled Medications Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Devices for Inhaled Medications Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Devices for Inhaled Medications by Region (2012-2017)
Figure EMEA Devices for Inhaled Medications Revenue Market Share Regions in 2016
Table EMEA Devices for Inhaled Medications Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Devices for Inhaled Medications Revenue and Growth Rate (2012-2017)
Table Europe Devices for Inhaled Medications Sales (K Units) by Type (2012-2017)
Table Europe Devices for Inhaled Medications Market Share by Type (2012-2017)
Figure Europe Devices for Inhaled Medications Market Share by Type in 2016
Table Europe Devices for Inhaled Medications Sales (K Units) by Application (2012-2017)
Table Europe Devices for Inhaled Medications Market Share by Application (2012-2017)
Figure Europe Devices for Inhaled Medications Market Share by Application in 2016
Table Europe Devices for Inhaled Medications Sales (K Units) by Countries (2012-2017)
Table Europe Devices for Inhaled Medications Sales Market Share by Countries (2012-2017)
Figure Europe Devices for Inhaled Medications Sales Market Share by Countries (2012-2017)
Figure Europe Devices for Inhaled Medications Sales Market Share by Countries in 2016
Table Europe Devices for Inhaled Medications Revenue (Million USD) by Countries (2012-2017)
Table Europe Devices for Inhaled Medications Revenue Market Share by Countries (2012-2017)
Figure Europe Devices for Inhaled Medications Revenue Market Share by Countries (2012-2017)
Figure Europe Devices for Inhaled Medications Revenue Market Share by Countries in 2016
Figure Germany Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure France Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure UK Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Devices for Inhaled Medications Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Devices for Inhaled Medications Sales (K Units) by Type (2012-2017)
Table Middle East Devices for Inhaled Medications Market Share by Type (2012-2017)
Figure Middle East Devices for Inhaled Medications Market Share by Type (2012-2017)
Table Middle East Devices for Inhaled Medications Sales (K Units) by Applications (2012-2017)
Table Middle East Devices for Inhaled Medications Market Share by Applications (2012-2017)
Figure Middle East Devices for Inhaled Medications Sales Market Share by Application in 2016
Table Middle East Devices for Inhaled Medications Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Devices for Inhaled Medications Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Devices for Inhaled Medications Sales Volume Market Share by Countries in 2016
Table Middle East Devices for Inhaled Medications Revenue (Million USD) by Countries (2012-2017)
Table Middle East Devices for Inhaled Medications Revenue Market Share by Countries (2012-2017)
Figure Middle East Devices for Inhaled Medications Revenue Market Share by Countries (2012-2017)
Figure Middle East Devices for Inhaled Medications Revenue Market Share by Countries in 2016
Figure Saudi Arabia Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Devices for Inhaled Medications Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Devices for Inhaled Medications Sales (K Units) by Type (2012-2017)
Table Africa Devices for Inhaled Medications Sales Market Share by Type (2012-2017)
Figure Africa Devices for Inhaled Medications Sales Market Share by Type (2012-2017)
Figure Africa Devices for Inhaled Medications Sales Market Share by Type in 2016
Table Africa Devices for Inhaled Medications Sales (K Units) by Application (2012-2017)
Table Africa Devices for Inhaled Medications Sales Market Share by Application (2012-2017)
Figure Africa Devices for Inhaled Medications Sales Market Share by Application (2012-2017)
Table Africa Devices for Inhaled Medications Sales Volume (K Units) by Countries (2012-2017)
Table Africa Devices for Inhaled Medications Sales Market Share by Countries (2012-2017)
Figure Africa Devices for Inhaled Medications Sales Market Share by Countries (2012-2017)
Figure Africa Devices for Inhaled Medications Sales Market Share by Countries in 2016
Table Africa Devices for Inhaled Medications Revenue (Million USD) by Countries (2012-2017)
Table Africa Devices for Inhaled Medications Revenue Market Share by Countries (2012-2017)
Figure Africa Devices for Inhaled Medications Revenue Market Share by Countries (2012-2017)
Figure Africa Devices for Inhaled Medications Revenue Market Share by Countries in 2016
Figure South Africa Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Table Consort Medical Devices for Inhaled Medications Basic Information List
Table Consort Medical Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Consort Medical Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Consort Medical Devices for Inhaled Medications Sales Market Share in EMEA (2012-2017)
Figure Consort Medical Devices for Inhaled Medications Revenue Market Share in EMEA (2012-2017)
Table Inhalexper Devices for Inhaled Medications Basic Information List
Table Inhalexper Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Inhalexper Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Inhalexper Devices for Inhaled Medications Sales Market Share in EMEA (2012-2017)
Figure Inhalexper Devices for Inhaled Medications Revenue Market Share in EMEA (2012-2017)
Table Cambridge Consultants Devices for Inhaled Medications Basic Information List
Table Cambridge Consultants Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cambridge Consultants Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Cambridge Consultants Devices for Inhaled Medications Sales Market Share in EMEA (2012-2017)
Figure Cambridge Consultants Devices for Inhaled Medications Revenue Market Share in EMEA (2012-2017)
Table Hovione Devices for Inhaled Medications Basic Information List
Table Hovione Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hovione Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Hovione Devices for Inhaled Medications Sales Market Share in EMEA (2012-2017)
Figure Hovione Devices for Inhaled Medications Revenue Market Share in EMEA (2012-2017)
Table Catalent, Inc Devices for Inhaled Medications Basic Information List
Table Catalent, Inc Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Catalent, Inc Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Catalent, Inc Devices for Inhaled Medications Sales Market Share in EMEA (2012-2017)
Figure Catalent, Inc Devices for Inhaled Medications Revenue Market Share in EMEA (2012-2017)
Table VertMarkets, Inc Devices for Inhaled Medications Basic Information List
Table VertMarkets, Inc Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure VertMarkets, Inc Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure VertMarkets, Inc Devices for Inhaled Medications Sales Market Share in EMEA (2012-2017)
Figure VertMarkets, Inc Devices for Inhaled Medications Revenue Market Share in EMEA (2012-2017)
Table Qualicaps Devices for Inhaled Medications Basic Information List
Table Qualicaps Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Qualicaps Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Qualicaps Devices for Inhaled Medications Sales Market Share in EMEA (2012-2017)
Figure Qualicaps Devices for Inhaled Medications Revenue Market Share in EMEA (2012-2017)
Table 3M Devices for Inhaled Medications Basic Information List
Table 3M Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure 3M Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure 3M Devices for Inhaled Medications Sales Market Share in EMEA (2012-2017)
Figure 3M Devices for Inhaled Medications Revenue Market Share in EMEA (2012-2017)
Table Aerovance Devices for Inhaled Medications Basic Information List
Table Aerovance Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aerovance Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure Aerovance Devices for Inhaled Medications Sales Market Share in EMEA (2012-2017)
Figure Aerovance Devices for Inhaled Medications Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Devices for Inhaled Medications Basic Information List
Table AstraZeneca Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Devices for Inhaled Medications Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Devices for Inhaled Medications Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim Devices for Inhaled Medications Basic Information List
Table Chiesi Devices for Inhaled Medications Basic Information List
Table Cipla Devices for Inhaled Medications Basic Information List
Table Civitas/Alkermes Devices for Inhaled Medications Basic Information List
Table GlaxoSmithKline Devices for Inhaled Medications Basic Information List
Table Hovione Devices for Inhaled Medications Basic Information List
Table Mannkind Devices for Inhaled Medications Basic Information List
Table Mantecorp Devices for Inhaled Medications Basic Information List
Table Meda Devices for Inhaled Medications Basic Information List
Table MicroDose Therapeutx Devices for Inhaled Medications Basic Information List
Table Novartis Devices for Inhaled Medications Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Devices for Inhaled Medications
Figure Manufacturing Process Analysis of Devices for Inhaled Medications
Figure Devices for Inhaled Medications Industrial Chain Analysis
Table Raw Materials Sources of Devices for Inhaled Medications Major Manufacturers in 2016
Table Major Buyers of Devices for Inhaled Medications
Table Distributors/Traders List
Figure EMEA Devices for Inhaled Medications Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Devices for Inhaled Medications Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Devices for Inhaled Medications Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Devices for Inhaled Medications Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Devices for Inhaled Medications Sales Market Share Forecast by Region (2017-2022)
Table EMEA Devices for Inhaled Medications Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Devices for Inhaled Medications Revenue Market Share Forecast by Region (2017-2022)
Table Europe Devices for Inhaled Medications Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Devices for Inhaled Medications Sales Market Share Forecast by Countries (2017-2022)
Table Europe Devices for Inhaled Medications Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Devices for Inhaled Medications Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Devices for Inhaled Medications Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Devices for Inhaled Medications Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Devices for Inhaled Medications Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Devices for Inhaled Medications Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Devices for Inhaled Medications Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Devices for Inhaled Medications Sales Market Share Forecast by Countries (2017-2022)
Table Africa Devices for Inhaled Medications Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Devices for Inhaled Medications Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Devices for Inhaled Medications Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Devices for Inhaled Medications Sales Market Share Forecast by Type (2017-2022)
Table EMEA Devices for Inhaled Medications Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Devices for Inhaled Medications Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources